16802 results for "sec+and+unspecified+malignant+neoplasm"

in 19.10 milliseconds.

• Leucocyte eQTLs in autoimmune disease and health

  Dac EGAC00001000338

• Multiple esclerosis and mixed microbial infections DAC

  Dac EGAC00001000892

• 16S rRNA gene amplification and maternal factors DAC

  Dac EGAC00001000931

• Pathology and tumor biology

  Dac EGAC00001001923

• Sarcoma biology and genomics data access commitee

  Dac EGAC00001002609

• Sarcoma biology and genomics data access committee

  Dac EGAC00001002610

• Pheochromocytoma and paraganglioma single nuclei RNA-seq

  Dac EGAC00001002657

• Computational Cancer Genomics and Tumor Evolution Group

  Dac EGAC00001002722

• MSAT and JMS Data Access Committee

  Dac EGAC00001002734

• Human islet sQTL and eQTL DAC

  Dac EGAC00001002796

• Annie Huang and the Hospital for Sick Children

  Dac EGAC01000000015

• Genomics and Oncogenesis of Pediatric Brain Tumors

  Dac EGAC00001003123

• DAC - Institute for Pharmacology and Toxicology

  Dac EGAC00001003385

• DAC Bone and soft tissue tumor pathology

  Dac EGAC50000000228

• RNASeq Javelin head and neck 100

  Study EGAS00001007497

• A Collaborative Search for New Genes for Non-Syndromic Deafness

  We seek to identify the DNA variants underlying sensorineural hearing loss. We obtain the DNA sequence of affected individuals and their family members. DNA variants are filtered to determine their segregation in affected families.

  Study phs003701

• Comprehensive genomic analysis for AYA with acute lymphoblastic leukemia

  AYA with B-ALL showed extremely inferior outcomes when compared to children. Genetic basis undelying AYA B-ALL is largely unknown. We performed integrated analysis of RNA-seq (hum0045���JGAS000047) and target DNA-seq.

  Study JGAS000276

• Mitochondrial DNA Mutations at Low-level Heteroplasmy in Chronic Kidney Disease

  To explore for relationship between somatic or heteroplasmic mutations of mtDNA and kidney function, we here performed ultra-deep sequencing based on long-range PCR from DNAs of 78 CKD kidney tissues.

  Study JGAS000611

• Cell-free DNA sequencing using newly developed single-strand DNA library preparation

  We performed whole genome sequencing of cell-free DNA that was collected from human plasma using an improved cfDNA purification protocol and DNA library prepared with newly developped protocol of our own.

  Study JGAS000257

• WTCCC case-control study for Hypertension - Combined Controls

  WTCCC genome-wide case-control association study for Hypertension (HT) using six disease collections together with the 1958 British Birth Cohort and the UK National Blood Service collections as controls.

  Study EGAS00000000010

• SCLC

  The aim of this study is to use sequence data generated from 500 bp paired end reads using the Illumina platform to characterise the breakpoints of chromosomal translocations, amplifications and deletions at high resolution (to the bp).

  Study EGAS00001000009

• Using Exome-sequencing to characterize the resistance to lirafugratinib

  We characterized resistance to lirafugratinib with whole exome sequencing in patients with FGFR2-driven cancers, treated in the phase 1/2 ReFocus trial (NCT04526106) and enrolled in the UNLOCK program at Gustave Roussy

  Study EGAS50000001371

• CIAO Clinical Trial

  Whole exome and RNA sequencing for samples from CIAO (Checkpoint Inhibitors Assessment in Oropharynx cancer) (NCT03144778) clinical trial testing neoadjuvant anti-PD-L1 durvalumab with or without the anti-CTLA-4 tremelimumab in oropharynx cancer

  Study EGAS50000001174

• Genome_wide_CRISPR_Cas9_screening_of_Human_Organoids

  In this study we will exploit the bacterial clustered regularly interspaced short palindromic repeats (CRISPR) system to perform a genome-wide single-guide RNA (sgRNA) library to screen for genes required for proliferation and survival in human organoids.

  Study EGAS00001001932

• Raw sequencing of single-cell RNA-seq data of a phase II clinical trial (NCT03419481)

  This is a single-arm Phase II trial of pembrolizumab in patients with hepatitis B virus-related hepatocellular carcinoma with parallel study on baseline and serial change in the immune environment.

  Study EGAS50000001315